Longevity Biotech will be attending the 8th Annual Neuroscience Innovation Forum
12th January 2025 – San Francisco

Longevity Biotech initiates Phase Ib Clinical Trial for LBT-3627
Nov 26, 2024 – Melbourne AU

Longevity Biotech will be attending the 2nd Annual Fluid & Imaging Biomarkers & Endpoints in Neuroscience Summit
Oct 22-24, 2024 – Boston

Longevity Biotech initiates Phase Ia Clinical Trial for LBT-3627
July 16, 2024 – Melbourne AU

Longevity Biotech will be attending the 6th Annual Treg-Directed Therapies Summit
March 25-27th, 2024 – Boston

Longevity Biotech will be presenting at the Society for Neuroimmune Pharmacology Conference (SNIP)
March 11-13, 2024 – Charleston, SC

Longevity Biotech will be attending the JP Morgan Healthcare conference
January 8-11, 2024 – San Francisco

Longevity Biotech will be attending the 5th Annual Treg-Directed Therapies Summit
May 30- June 1, 2023 – Boston

Longevity Biotech will be attending the JP Morgan Healthcare conference
January 8-11, 2023- San Francisco

Longevity Biotech receives funding from Michael J. Fox Foundation to advance LBT-3627 into clinical trials
March 9th, 2022

Longevity Biotech will be presenting at the Neuroimmunology Drug Development Summit
April 27-29, 2021 – Virtual Event

Longevity Biotech will be presenting at the Longevity Therapeutics Conference
January 26-28, 2021 – Virtual Event

Longevity Biotech will be attending the Biotech In Europe Forum (BEF)
September 21 – 24, 2020 – Virtual Event

Longevity Biotech will be presenting at the Biomarkers for Alzheimer’s Disease Summit
July 15, 2020 – Virtual Event

Longevity Biotech awarded grant by Department of Defense for ALS
April 1, 2020 – Philadelphia, PA

Longevity Biotech will be attending the JP Morgan Healthcare conference
January 12 – 16, 2020 – San Francisco